Cessatech A/S

Cessatech is a pivotal-stage paediatric biotech company developing first-in-class specialty hospital medicines for children, focused on high-impact unmet needs in acute and emergency care. The company focuses on specialty products designed for use in clinical settings and advances its programs through a partnership-based development model. Founded in 2020, Cessatech is headquartered in Denmark and led by a team with experience across drug development and commercialization.

Quotes

Board

CEO

Jes Trygved

Chairperson of the Board

Martin Olin

Board

Charlotte Videbæk
Flemming Steen Jensen
Rachel Curtis Gravesen

Powered by Modular Finance

*Powered by Modular Finance

Key Numbers

	2026-06-30	2026-03-31	2025-12-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Number of months that the report spans	Q2 3 Months	Q1 3 Months	2025	Q4 3 Months	Q3 3 Months	Q2 3 Months	Q1 3 Months
Total revenue MDKK	0.00	0.00	5.72	1.99	-1.24	-1.24	-1.24
Earnings before interest and tax MDKK	-3.47	-3.76	-14.97	-1.84	-3.97	-3.55	-5.61
Profit before tax MDKK	-3.46	-3.78	-14.97	-1.81	-3.98	-3.56	-5.62
Net profit MDKK	-2.77	-3.23	-10.90	-0.77	-3.05	-2.79	-4.30
Earnings per share DKK	-0.15	-0.17	-0.60	-0.04	-0.16	-0.16	-0.25
Dividend per share DKK	0,00	0,00	0.00	0.00	0,00	0,00	0,00
Equity MDKK	6.39	9.06	12.16	12.16	13.15	15.95	4.40
Fixed assets MDKK	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible assets MDKK	0.20	0.20	0.20	0.20	0.20	0.20	0.20
Current assets MDKK	8.13	10.24	13.19	13.19	15.51	21.13	11.07
Total asset MDKK	8.33	10.44	13.39	13.39	15.71	21.33	11.27
Long term liabilities MDKK	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current liabilities MDKK	1.94	1.38	1.23	1.23	2.56	5.38	6.87
Number of shares DKK	18576437.00	18576437.00	18576437.00	18576437.00	18576437.00	18576437.00	17425094.00